GlassScriptPhysician profile
Demetris Natasha Wright
NPI 1023406774
$1,094.22
in general payments reported to CMS, 2019-2025
17 companies · $22.07 in 2025
The $22.07 reported for 2025 was less than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $384 · 2022: $599 · 2023: $39.54 · 2024: $49.11 · 2025: $22.07.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $111.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $110.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sunovion Pharmaceuticals INC. | $181.89 | 2021-2022 | |
| Lundbeck LLC | $134.74 | 2021-2024 | Rexulti |
| Takeda Pharmaceuticals U.S.A., INC. | $132.65 | 2021-2022 | |
| Alkermes, INC. | $87.63 | 2021-2022 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $86.62 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $83.80 | 2021-2023 | Spravato |
| Vanda Pharmaceuticals INC. | $79.64 | 2021-2022 | |
| Abbvie INC. | $70.17 | 2021-2023 | |
| Neurocrine Biosciences, INC. | $49.09 | 2022-2024 | Ingrezza |
| Avanir Pharmaceuticals, INC. | $41.46 | 2022 | |
| Eisai INC. | $30.37 | 2021-2022 | |
| Otsuka America Pharmaceutical, INC. | $25.96 | 2021-2024 | Rexulti |
| Owp Pharmaceuticals, INC. | $23.74 | 2021 | |
| Abbott Laboratories | $22.07 | 2025 | Amplatzer Amulet |
| Bausch Health US, LLC | $15.72 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Almatica Pharma LLC | $14.62 | 2021 | |
| Gilead Sciences, INC. | $14.05 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Demetris Wright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.